Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today data from a new study examining the immunogenicity and ...
- Cette souche vaccinale est utilisée dans la production du vaccin oral contre le virus polio de type 3 - Sanofi Pasteur, la division vaccins de...
The Sounds of Pertussis(R) Campaign motors into New York City today to rev up the third annual Pertussis Awareness Day with an array of educational...
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that it began shipping its 2011-2012 Fluzone®...
-Une solide expérience biopharmaceutiquepour le développement futur de la joint-venture européenne - MSD, dénommé Merck aux Etats-Unis et au Canada...
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), offers its congratulations to the four winners of the International...
Strategic Canadian asset puts Ontario at the heart of global vaccine innovation To view the Social Media Release, click here:...
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the U.S. Food and Drug Administration (FDA) has...
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug...
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), today will participate in the first international...
- Sanofi Pasteur solidaire du Rotary International dans la mobilisation pour sauver des vies aux cérémonies du NYSE et d'Euronext Sanofi Pasteur, la...
Sanofi Pasteur, la division vaccins du Groupe sanofi-aventis (EURONEXT : SAN et NYSE : SNY), annonce aujourd'hui son alliance avec l'International...
Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that it is partnering with the...
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has started its phase II clinical study of a vaccine for...
Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug...
- First Phase 3 Study Underway in Australia Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced...
Sanofi Pasteur, la división de vacunas del Grupo sanofi-aventis (EURONEXT: SAN y NYSE: SNY), anunció hoy que su vacuna contra el dengue ya está...
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today the results of a clinical trial of...
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today the results of the Phase III...
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), has been awarded a three-year contract for $56.94...
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY) announced today that it has signed a binding...
Sanofi Pasteur, la división vacunas del Grupo Sanofi-aventis, anunció hoy el inicio de un nuevo estudio clínico con niños y adolescentes, en Brasil,...
TORONTO, Sept. 14 /PRNewswire-FirstCall/ - To view this Social Media Release, please enter the following address in your web browser....
Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that it has filed a Supplemental...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.